ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 161 filers reported holding ANTARES PHARMA INC in Q4 2019. The put-call ratio across all filers is 5.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $55,000 | +1.9% | 13,500 | 0.0% | 0.00% | – |
| Q4 2020 | $54,000 | +50.0% | 13,500 | 0.0% | 0.00% | – |
| Q3 2020 | $36,000 | -2.7% | 13,500 | 0.0% | 0.00% | – |
| Q2 2020 | $37,000 | +15.6% | 13,500 | 0.0% | 0.00% | – |
| Q1 2020 | $32,000 | -49.2% | 13,500 | 0.0% | 0.00% | – |
| Q4 2019 | $63,000 | +40.0% | 13,500 | 0.0% | 0.00% | – |
| Q3 2019 | $45,000 | +2.3% | 13,500 | 0.0% | 0.00% | – |
| Q2 2019 | $44,000 | +7.3% | 13,500 | -0.4% | 0.00% | – |
| Q1 2019 | $41,000 | +10.8% | 13,553 | 0.0% | 0.00% | – |
| Q4 2018 | $37,000 | -24.5% | 13,553 | -7.8% | 0.00% | – |
| Q3 2018 | $49,000 | +40.0% | 14,694 | +6.8% | 0.00% | – |
| Q2 2018 | $35,000 | +16.7% | 13,753 | +1.9% | 0.00% | – |
| Q1 2018 | $30,000 | +11.1% | 13,500 | 0.0% | 0.00% | – |
| Q4 2017 | $27,000 | -64.5% | 13,500 | -42.6% | 0.00% | – |
| Q3 2017 | $76,000 | -10.6% | 23,500 | -11.3% | 0.00% | – |
| Q2 2017 | $85,000 | +13.3% | 26,500 | 0.0% | 0.00% | – |
| Q1 2017 | $75,000 | +21.0% | 26,500 | 0.0% | 0.00% | – |
| Q4 2016 | $62,000 | +34.8% | 26,500 | -2.9% | 0.00% | – |
| Q3 2016 | $46,000 | +58.6% | 27,300 | 0.0% | 0.00% | – |
| Q2 2016 | $29,000 | +20.8% | 27,300 | 0.0% | 0.00% | – |
| Q1 2016 | $24,000 | -11.1% | 27,300 | +22.4% | 0.00% | – |
| Q4 2015 | $27,000 | +200.0% | 22,300 | +346.0% | 0.00% | – |
| Q3 2015 | $9,000 | -35.7% | 5,000 | 0.0% | 0.00% | – |
| Q1 2015 | $14,000 | +7.7% | 5,000 | 0.0% | 0.00% | – |
| Q4 2014 | $13,000 | +44.4% | 5,000 | 0.0% | 0.00% | – |
| Q3 2014 | $9,000 | +50.0% | 5,000 | +127.3% | 0.00% | – |
| Q2 2014 | $6,000 | -93.5% | 2,200 | -91.6% | 0.00% | -100.0% |
| Q1 2014 | $92,000 | +820.0% | 26,200 | +1090.9% | 0.00% | – |
| Q4 2013 | $10,000 | -54.5% | 2,200 | -58.8% | 0.00% | – |
| Q3 2013 | $22,000 | +100.0% | 5,346 | +98.0% | 0.00% | – |
| Q2 2013 | $11,000 | – | 2,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 1,671,956 | $5,384,000 | 3.43% |
| ARMISTICE CAPITAL, LLC | 5,700,000 | $18,354,000 | 2.34% |
| Rubric Capital Management LP | 3,188,600 | $10,267,000 | 2.12% |
| Broadfin Capital, LLC | 4,803,528 | $15,467,000 | 1.88% |
| THOMPSON DAVIS & CO., INC. | 192,734 | $621,000 | 1.00% |
| Asymmetry Capital Management, L.P. | 199,655 | $643,000 | 0.76% |
| Perceptive Advisors | 4,267,253 | $13,741,000 | 0.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 946,987 | $3,049,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $886,000 | 0.20% |
| EAM Investors, LLC | 251,619 | $810,000 | 0.13% |